Sustainable, Alginate-Based Sensor for Detection of Escherichia coli in Human Breast Milk

There are no existing affordable diagnostics for sensitive, rapid, and on-site detection of pathogens in milk. To this end, an on-site colorimetric-based sustainable assay has been developed and optimized using an L16 (54) Taguchi design to obtain results in hours without PCR amplification. To determine the level of Escherichia coli (E. coli) contamination, after induction with 150 µL of breast milk, the B-Per bacterial protein extraction kit was added to a solution containing an alginate-based microcapsule assay. Within this 3 mm spherical novel sensor design, X-Gal (5-Bromo-4-Chloro-3-Indolyl β-D-Galactopyranoside) was entrapped at a concentration of 2 mg/mL. The outward diffusing X-Gal was cleaved by β-galactosidase from E. coli and dimerized in the solution to yield a blue color after incubation at 40 °C. Color intensity was correlated with the level of E. coli contamination using a categorical scale. After an 8 h incubation period, a continuous imaging scale based on intensity normalization was used to determine a binary lower limit of detection (LOD), which corresponded to 102 colony forming unit per mL (CFU/mL) and above. The cost of the overall assay was estimated to be $0.81 per sample, well under the$3 benchmark for state-of-the-art immune-based test kits for pathogen detection in biofluids. Considering the reported binary LOD cutoff of 102 CFU/mL and above, this proposed hydrogel-based assay is suited to meet global requirements for screening breast milk or milk for pathogenic organisms of 104 CFU/mL, with a percentage of false positives to be determined in future efforts

Sustainable, Alginate-Based Sensor for Detection of Escherichia coli in Human Breast Milk

There are no existing affordable diagnostics for sensitive, rapid, and on-site detection of pathogens in milk. To this end, an on-site colorimetric-based sustainable assay has been developed and optimized using an L16 (54) Taguchi design to obtain results in hours without PCR amplification. To determine the level of Escherichia coli (E. coli) contamination, after induction with 150 µL of breast milk, the B-Per bacterial protein extraction kit was added to a solution containing an alginate-based microcapsule assay. Within this 3 mm spherical novel sensor design, X-Gal (5-Bromo-4-Chloro-3-Indolyl β-d-Galactopyranoside) was entrapped at a concentration of 2 mg/mL. The outward diffusing X-Gal was cleaved by β-galactosidase from E. coli and dimerized in the solution to yield a blue color after incubation at 40 °C. Color intensity was correlated with the level of E. coli contamination using a categorical scale. After an 8 h incubation period, a continuous imaging scale based on intensity normalization was used to determine a binary lower limit of detection (LOD), which corresponded to 102 colony forming unit per mL (CFU/mL) and above. The cost of the overall assay was estimated to be $0.81 per sample, well under the$3 benchmark for state-of-the-art immune-based test kits for pathogen detection in biofluids. Considering the reported binary LOD cutoff of 102 CFU/mL and above, this proposed hydrogel-based assay is suited to meet global requirements for screening breast milk or milk for pathogenic organisms of 104 CFU/mL, with a percentage of false positives to be determined in future efforts

The Comparison of Exosome and Exosomal Cytokines between Young and Old Individuals with or without Gastric Cancer

Summary: Background: Exosomes are small extracellular vesicles secreted by various types of cells. Exosomes play an important role in intercellular communication by serving as vehicles for transferring proteins, lipids, mRNAs, microRNAs, and DNAs to recipient cells. This study investigated the role of exosomes in gastric cancer and the aging process by using a large number of human serum samples from young and aged individuals with or without gastric cancer. Methods: The age- and cancer-associated changes in exosome levels and exosomal cytokine content were measured. Exosomes in human serum were isolated by using a total exosome isolation reagent, followed by a quantification of isolated exosomes using a MicroBCA assay. Exosomal cytokines were measured by ELISA. Results: Serum exosome levels are increased by cancer and aging. Exosomal levels of TNF-α and TGF-β are increased, whereas IL-10 levels are reduced in gastric cancer. In addition, the cancer-associated changes in exosomal cytokines remain constant with age, even though aging affects every type of immune cells and immunomodulating factors. Conclusion: Gastric cancer and aging affect serum exosome and exosomal cytokines levels. Future studies would require the analysis of more diverse cytokines in exosomes derived from multiple types of cancer. Keywords: exosome, microvesicle, aging, cancer, cytokin